Cc. Gerhardt et al., MOLECULAR-CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A MOLLUSCANOCTOPAMINE RECEPTOR, Molecular pharmacology, 51(2), 1997, pp. 293-300
We describe the cloning and functional expression of a cDNA encoding a
novel G protein-coupled receptor, which was isolated from the central
nervous system of the pond snail Lymnaea stagnalis. The amino acid se
quence predicted by this cDNA shows highest similarity with the sequen
ce of the Locusta tyramine receptor, the Drosophila tyramine/octopamin
e receptor, and the mammalian alpha-adrenergic receptors. On expressio
n in mammalian cells, [H-3]rauwolscine, an alpha(2)-adrenergic recepto
r antagonist, binds with high affinity (K-D = 2.9 x 10(-9) M) to the r
eceptor. Of several tested neurotransmitters, octopamine (which is con
sidered to be the invertebrate counterpart of norepinephrine) showed t
he highest affinity (1.9 x 10(-6) M) for the receptor. Therefore, we c
onsider this receptor to be the first true octopamine receptor to be c
loned. The ligand binding properties of the novel receptor, designated
Lym oa(1), seem to be distinct from any of the binding profiles descr
ibed for octopamine receptors in tissue preparations. Although the pha
rmacological profile of Lym oa(1) shows some similarity with that of T
yr/Oct-Dro and Tyr-Loc, there are also clear differences. In particula
r, phentolamine, chlorpromazine, and mianserine display markedly highe
r affinities for Lym oa(1) than for the insect receptors. As far as th
e vertebrate adrenergic receptors are concerned, the ligand binding pr
operties of Lym oa(1) resemble alpha(2)-adrenergic receptors more than
they do alpha(1)- or beta-adrenergic receptors. Octopaminergic stimul
ation of Lym oa(1) induces an increase in both inositol phosphates and
cAMP (EC(50) = 9.1 x 10(-7) M and 5.1 x 10(-6) M, respectively). This
is in contrast to the signal transduction pathways described for the
related tyramine- and alpha(2)-adrenergic receptors, which couple in a
n inhibitory way to adenylyl cyclase.